- New Online Knowledge Hub Aims to Become Leading Forum for MalariaResearchers, Editors and Opinion Leaders
Advertisement
Elsevier, the world-leading publisher of scientific, technical andmedical information products and services, today announced the launch ofMalaria Nexus, Elsevier's Global Malaria Resource,http://www.malarianexus.com.
Advertisement
Malaria Nexus highlights the latest published research in Malaria,utilizing Elsevier's leading journals in Parasitology, Entomology andTropical Medicine, including The Lancet(R), The Lancet Infectious Diseases,Transactions of the Royal Society of Tropical Medicine and Hygiene, andInternational Journal for Parasitology.
"The aim of Malaria Nexus is to be a comprehensive resource and hub ofknowledge for malaria researchers worldwide" said Dale Seaton, ExecutivePublisher for Parasitology, at Elsevier. "As well as making our latestmalaria publications free to download, we want to go beyond the article, andbecome a leading forum for discussion between researchers, editors andopinion leaders."
The site features interviews with key authors, who can expand on theirhighlighted published work, as well as editors of some of Elsevier's mostprestigious journal titles. Active participation and feedback from interestedparties is encouraged. Currently featuring article feeds from 13 journals,the site will include additional relevant journals over the coming months.
John Beier, Editor of the participating journal Acta Tropica, said, "Fromremote settings in malaria endemic areas to sophisticated laboratories,malaria researchers from around the world will certainly benefit from usingMalaria Nexus by reading timely highlights of first class publications,learning the views of leading malaria experts, and expressing their importantopinions in this new forum for exchange of information."
For more information visit the site http://www.malarianexus.com andregister for updates.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. The company works in partnershipwith the global science and health communities to publish more than 2,000journals, including The Lancet (http://www.thelancet.com) and Cell(http://www.cell.com), and close to 20,000 book titles, including majorreference works from Mosby and Saunders. Elsevier's online solutions includeScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) andNursing Consult (http://www.nursingconsult.com), which enhance theproductivity of science and health professionals, and the SciVal suite(http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com),which help research and health care institutions deliver better outcomes morecost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is partof Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leadingpublisher and information provider, which is jointly owned by Reed ElsevierPLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact Matthew Smaldon Group Marketing Communications Manager - Elsevier +44(0)1865-843644 [email protected]
SOURCE Elsevier
